Al Altomari

Al Altomari is the president and chief executive officer of Agile Therapeutics and a member of the company's board of directors. Prior to being named president and CEO, Mr. Altomari served as Agile's executive chairman in which capacity he closed a $45 million venture round in May 2010. Mr. Altomari has more than 28 years of experience in the pharmaceutical industry, with more than 20 years focused on the development and marketing of specialty pharmaceutical products. Currently Mr. Altomari is leading Agile through the final stages of development and commercialization of contraceptive products using the company's proprietary transdermal technology. ... Read More